The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
So, so in in this in this um area of NAD consuming enzymes, there's PARPs. PARP one was kind of the first one that was described, but there another 15 or 16 members of the PARP super family. Many of them don't polymerize ADP ribos, but they modify proteins with ADP ribos. So they they they cut NAD and they add an ADP ribos unit on something to do a signaling reaction.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.